376 related articles for article (PubMed ID: 18157698)
1. Acromegaly: re-thinking the cancer risk.
Loeper S; Ezzat S
Rev Endocr Metab Disord; 2008 Mar; 9(1):41-58. PubMed ID: 18157698
[TBL] [Abstract][Full Text] [Related]
2. Medical consequences of acromegaly: what are the effects of biochemical control?
Colao A; Auriemma RS; Pivonello R; Galdiero M; Lombardi G
Rev Endocr Metab Disord; 2008 Mar; 9(1):21-31. PubMed ID: 18163212
[TBL] [Abstract][Full Text] [Related]
3. Cancers associated with acromegaly.
Jenkins PJ
Neuroendocrinology; 2006; 83(3-4):218-23. PubMed ID: 17047386
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly and cancer.
Jenkins PJ
Horm Res; 2004; 62 Suppl 1():108-15. PubMed ID: 15761242
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspective: acromegaly and cancer: a problem.
Jenkins PJ; Besser M
J Clin Endocrinol Metab; 2001 Jul; 86(7):2935-41. PubMed ID: 11443146
[No Abstract] [Full Text] [Related]
6. Does acromegaly enhance mortality?
Ayuk J; Sheppard MC
Rev Endocr Metab Disord; 2008 Mar; 9(1):33-9. PubMed ID: 18075787
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly, growth hormone and cancer risk.
Renehan AG; Brennan BM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
[TBL] [Abstract][Full Text] [Related]
8. Oncological complications of excess GH in acromegaly.
Webb SM; Casanueva F; Wass JA
Pituitary; 2002 Jan; 5(1):21-5. PubMed ID: 12638722
[TBL] [Abstract][Full Text] [Related]
9. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
10. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
[TBL] [Abstract][Full Text] [Related]
12. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer and acromegaly.
Corrêa LL; Lima GA; Paiva HB; Silva CM; Cavallieri SA; Miranda LC; Gadelha MR
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):963-8. PubMed ID: 20126848
[TBL] [Abstract][Full Text] [Related]
14. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
[TBL] [Abstract][Full Text] [Related]
15. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
[TBL] [Abstract][Full Text] [Related]
16. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients.
Colao A; Marzullo P; Spiezia S; Giaccio A; Ferone D; Cerbone G; Di Sarno A; Lombardi G
J Clin Endocrinol Metab; 2000 Oct; 85(10):3754-61. PubMed ID: 11061535
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer is the most common cancer associated with acromegaly.
Gullu BE; Celik O; Gazioglu N; Kadioglu P
Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
19. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels in acromegaly patients.
Hekimsoy Z; Ozmen B; Ulusoy S
Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
